These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39375095)

  • 1. [Advances in molecular characteristics of pediatric meningiomas].
    Hou XY; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2024 Oct; 53(10):1065-1069. PubMed ID: 39375095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.
    Kalamarides M; Niwa-Kawakita M; Leblois H; Abramowski V; Perricaudet M; Janin A; Thomas G; Gutmann DH; Giovannini M
    Genes Dev; 2002 May; 16(9):1060-5. PubMed ID: 12000789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
    J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
    Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
    Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization.
    Begnami MD; Rushing EJ; Santi M; Quezado M
    Int J Surg Pathol; 2007 Apr; 15(2):110-5. PubMed ID: 17478763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
    Shankar GM; Abedalthagafi M; Vaubel RA; Merrill PH; Nayyar N; Gill CM; Brewster R; Bi WL; Agarwalla PK; Thorner AR; Reardon DA; Al-Mefty O; Wen PY; Alexander BM; van Hummelen P; Batchelor TT; Ligon KL; Ligon AH; Meyerson M; Dunn IF; Beroukhim R; Louis DN; Perry A; Carter SL; Giannini C; Curry WT; Cahill DP; Barker FG; Brastianos PK; Santagata S
    Neuro Oncol; 2017 Apr; 19(4):535-545. PubMed ID: 28170043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and merlin tumor suppressors: Two of a kind.
    Voltan R
    EBioMedicine; 2018 Nov; 37():23-24. PubMed ID: 30385232
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular and genetic profiles of radiographically defined de novo meningiomas.
    Kitamura Y; Sasaki H; Yoshida K
    J Neurooncol; 2012 May; 108(1):37-44. PubMed ID: 22274402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 mutations in high-grade meningioma: implications for patient care.
    Shankar GM; Santagata S
    Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.
    Ongaratti BR; Silva CB; Trott G; Haag T; Leães CG; Ferreira NP; Oliveira MC; Pereira-Lima JF
    Braz J Med Biol Res; 2016; 49(4):e5125. PubMed ID: 27007654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells.
    Al-Khalaf HH; Lach B; Allam A; AlKhani A; Alrokayan SA; Aboussekhra A
    J Neurooncol; 2007 May; 83(1):9-15. PubMed ID: 17245624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic multiple meningiomas harbor distinct driver mutations.
    Juratli TA; Prilop I; Saalfeld FC; Herold S; Meinhardt M; Wenzel C; Zeugner S; Aust DE; Barker FG; Cahill DP; Brastianos PK; Santagata S; Schackert G; Pinzer T
    Acta Neuropathol Commun; 2021 Jan; 9(1):8. PubMed ID: 33407897
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
    Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
    J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Melanoma of the Leptomeninges with BAP1 Expression-Loss in the Setting of a Nevus of Ota: A Clinical, Morphological and Genetic Study of 2 Cases.
    Goldman-Lévy G; Rigau V; Bléchet C; Bens G; Muckensturm B; Delage M; Labrousse F; Haddad V; Attignon V; Pissaloux D; de la Fouchardière A
    Brain Pathol; 2016 Jul; 26(4):547-50. PubMed ID: 26834043
    [No Abstract]   [Full Text] [Related]  

  • 20. Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    Lucas CG; Devine P; Solomon DA; Giannini C; Reifenberger G; Dahiya S; Caccamo D; Perry A
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):764-768. PubMed ID: 34128073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.